• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 29, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

KAIST Achieves Breakthrough in Restoring Complex Altered Gene Networks to Normal Function

Bioengineer by Bioengineer
August 29, 2025
in Health
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

blank

In a groundbreaking advancement that could redefine the future of precision medicine and cancer therapy, researchers at the Korea Advanced Institute of Science and Technology (KAIST) have unveiled a novel technology capable of restoring altered gene networks to their normal state. Led by Professor Kwang-Hyun Cho from the Department of Bio and Brain Engineering, this innovative approach leverages advanced algebraic methods to identify gene control targets within dysregulated cellular systems. Unlike traditional studies, which often relied on observing single stimulus-response events, this methodology addresses the intricate complexity of gene networks, promising a transformative impact on diverse biomedical fields, including drug development and cellular reprogramming.

At the heart of this breakthrough lies an algebraic approach that systematically models gene interactions within a cell as mathematical equations. By expressing gene regulatory networks through such a lens, the research team has achieved unprecedented precision in pinpointing genes whose modulation can revert pathological cellular responses back to their healthy equivalents. This method transcends conventional trial-and-error strategies, providing a rigorous computational framework to navigate vast gene interaction landscapes effectively.

To visualize the convoluted web of genetic interplay, the team depicted gene networks as logic circuit diagrams, specifically Boolean networks. This abstraction not only condenses the complexity of gene regulation but also facilitates the mapping of cellular behaviors onto a ‘phenotype landscape’. This landscape conceptualizes the spectrum of possible cellular states and responses, enabling an intuitive understanding of how cells react under varying stimuli and perturbations.

The key computational innovation underpinning this approach is the application of the semi-tensor product, a sophisticated mathematical tool that encapsulates all potential gene combinations and their control effects into a unified algebraic formula. This method allows for a comprehensive yet efficient exploration of gene regulatory dynamics, accelerating the identification of therapeutic intervention points in gene networks that were previously too complex to analyze exhaustively.

One of the primary challenges addressed by the KAIST team was the overwhelming complexity arising from the thousands of key genes influencing cellular fate. To surmount this, they integrated the Taylor approximation, a numerical technique that approximates complex equations with simpler ones without significant loss of accuracy. This clever simplification enabled the team to conduct rapid and reliable computations, drastically reducing the computational resources and time traditionally required for such analyses.

Through this combined mathematical framework, the researchers computed the stable states—or attractors—that cells tend to adopt under normal and aberrant conditions. More importantly, they simulated how altering the expression or activity of specific genes could shift cells from diseased attractor states back to their healthy counterparts. This predictive power marks a significant leap toward rational design of gene-targeted therapies.

To validate their technology, Professor Cho’s group applied it to diverse gene networks, including those implicated in bladder cancer and immune cell differentiation. Remarkably, in the context of bladder cancer, they identified gene targets whose modulation could restore the cells’ distorted stimulus-response patterns to normal function. Similarly, in immune cells undergoing differentiation, the system pinpointed key genetic levers capable of reestablishing proper cellular signaling despite large-scale network distortions.

This novel technique stands out from previous approaches, which often relied on approximate searches and laborious computer simulations prone to inefficiency. Instead, the KAIST method streamlines the control target identification process, offering a fast and systematic solution that holds potential for broad applications. As Prof. Cho notes, the study lays the groundwork for the next generation of digital biological modeling, specifically the Digital Cell Twin model.

The Digital Cell Twin aims to construct comprehensive virtual models of cellular processes, simulating complex gene interactions and cellular reactions in silico rather than through physical experiments. By integrating this control theory with digital twins, researchers envisage a future where phenotype landscapes can be manipulated virtually, allowing rapid testing and optimization of therapeutic strategies before clinical implementation.

Beyond its immediate technological significance, this discovery reflects a paradigm shift in biology, emphasizing computational precision and control theory to decode and rectify cellular dysregulation. Such an approach dovetails seamlessly with the ongoing trends in personalized medicine, where individualized cellular models guide tailored treatment regimens, offering hope for addressing challenging diseases like cancer through reversibility and reprogramming.

The research team, including master’s student Insoo Jung and PhD candidates Corbin Hopper, Seong-Hoon Jang, and Hyunsoo Yeo, collaborated extensively to bring this project to fruition. Their findings were published on August 22 in the prestigious journal Science Advances, providing the scientific community with detailed methodological insights and validation data.

Supported by Korea’s Ministry of Science and ICT through the National Research Foundation’s Mid-Career Researcher and Basic Research Laboratory Programs, this work exemplifies the synergy between mathematical innovation and biomedical research, heralding a new era in the understanding and control of gene regulatory networks. As further studies build upon this foundation, the prospect of controlling cellular behavior at a system-wide level moves ever closer to reality, promising groundbreaking therapies that could revolutionize human health.

Subject of Research: Not applicable

Article Title: “Reverse Control of Biological Networks to Restore Phenotype Landscapes”

News Publication Date: 22-Aug-2025

Web References: https://dx.doi.org/10.1126/sciadv.adw3995

References: Published in Science Advances by the American Association for the Advancement of Science (AAAS)

Image Credits: KAIST

Keywords: Human health

Tags: algebraic methods in geneticsbiomedical research innovationsBoolean networks in biologycancer therapy advancementscellular reprogramming techniquescomputational frameworks for gene interactionsdrug development strategiesdysregulated cellular systemsgene control targets identificationgene regulatory networks modelingKAIST gene network restorationprecision medicine breakthroughs

Share12Tweet7Share2ShareShareShare1

Related Posts

Dexamethasone’s Role in IVF for PCOS Patients

August 29, 2025

Modeling Mechanical Stresses in Breast Implants Under Dynamics

August 29, 2025

Household Activity Boosts Gray Matter in Seniors

August 29, 2025

Lymphotoxin Beta Receptor Loss Triggers Senescence via MDMX-p53

August 29, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    82 shares
    Share 33 Tweet 21

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

EGCG Reduces Septic Shock by Modulating CXCL2

Wedelolactone Triggers Pyroptosis to Suppress Retinoblastoma

Dexamethasone’s Role in IVF for PCOS Patients

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.